Cargando…
Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease
Aging is the biggest risk factor for developing many neurodegenerative disorders, including idiopathic Parkinson’s disease (PD). PD is still an incurable disorder and the available medications are mainly directed to the treatment of symptoms in order to improve the quality of life. Oxidative injury...
Autores principales: | De Lazzari, Federica, Bubacco, Luigi, Whitworth, Alexander J, Bisaglia, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065289/ https://www.ncbi.nlm.nih.gov/pubmed/30090659 http://dx.doi.org/10.14336/AD.2017.1018 |
Ejemplares similares
-
Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss
por: Biosa, Alice, et al.
Publicado: (2018) -
Superoxide Dismutase (SOD)-mimetic M40403 Is Protective in Cell and Fly Models of Paraquat Toxicity: IMPLICATIONS FOR PARKINSON DISEASE
por: Filograna, Roberta, et al.
Publicado: (2016) -
Antioxidant Therapy in Parkinson’s Disease: Insights from Drosophila melanogaster
por: De Lazzari, Federica, et al.
Publicado: (2020) -
Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant?
por: Bisaglia, Marco, et al.
Publicado: (2020) -
Etching of AuNPs Through Superoxide Radical Dismutation by Cu-Zn Superoxide Dismutase Resulted in Remarkable Changes of its Localized Surface Plasmon Resonance
por: Eghtedari, Masoumeh, et al.
Publicado: (2021)